Clinical Trials Arena on MSN2d
Trevi’s Phase IIb chronic cough success spikes stock by 71%
The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.
BioSpace10d
Lexicon to Advance Non-Opioid Painkiller Despite Mid-Stage Trial Failure
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
Morningstar15d
IRLAB Publishes Phase IIb Data on Mesdopetam in Movement Disorders Clinical Practice
The Phase Ib and Phase IIa studies showed a good safety and tolerability ... effect compared with current treatment options. A Phase IIb study, completed in 2023, showed that mesdopetam has ...
Business Insider28d
ORYZON Announces Journal Publication of Final Phase IIa REIMAGINE Results with Vafidemstat in Psychiatry and Clinical Neurosciences
The Phase IIa study REIMAGINE evaluated the safety and ... further clinical development in BPD After an informative Phase IIb in BPD and FDA EoPII meeting, preparations for the PORTICO-2 Phase ...
WAVY-TV1mon
AusperBio Reaches Key Milestone with Dosing Completion and Study Unblinding in Ongoing AHB-137 Phase IIb Trial
Dr. Chris Yang, Co-founder and CSO of AusperBio, added, "The Phase IIb interim data strengthens the exciting Phase IIa data presented at AASLD 2024, in terms of both HBsAg loss and seroconversion.
IRLAB Therapeutics: IRLAB Publishes Phase IIb Data on Mesdopetam in Movement Disorders Clinical Practice
GOTHENBURG, SWEDEN / ACCESS Newswire / February 27, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a compa ...